Novozymes Acquires Natural Industries
On Nov. 28, Novozymes announced that it had signed a definitive agreement to acquire Natural Industries Inc. based in Houston. Novozymes is is a biotech company with a strong focus on enzyme production and is headquartered in Copenhagen, Denmark.
“I am excited to have the people and technologies of Natural Industries Inc. join our growing BioAg business. Natural Industries Inc. expands Novozymes’ position in the important biocontrol segment and improves our capabilities to grow our business in key US markets on high-value crops like fruits and vegetables,” says Thomas Videbæk, executive vice president of Novozymes and head of BioBusiness.
Natural Industries Inc. and Novozymes have agreed not to disclose the financial terms of the agreement. The acquisition does not impact Novozymes’ financial guidance for 2012.
“Founded in 1992 and with 24 talented employees, Natural Industries Inc. brings a wealth of knowledge in the biocontrol area. The company has a proven portfolio of products, new pipeline opportunities and good market coverage for high value crops in key regions of the US. The acquisition is a good example how we can grow and use our
platform and leading position in this area as well as accelerate innovation,” Videbæk explains.
“Novozymes has long-term ambitions to be a key player in this market. With our platform today, our expertise within bioinnovation and R&D, we expect to continue to play a leading role in growing the bioagriculture market,” he added.
You can find additional information about Novozymes at www.novozymes.com. More information on Natural Industries products can be found at www.naturalindustries.com.
Video Library 
